It is widely accepted that disease prevention and risk-reduction strategies have the potential to lower disease burden as well as improve the overall health of individuals. POCT technology offers such potential for diagnosis and treatment of patients, as it facilitates rapid availability of test results and hence, early clinical decision making and intervention.
Amidst a rising disease incidence, reduced budget, growing focus towards personalization of care, and ever-increasing integration of technology into healthcare, the global POCT market is expected to grow to almost US$ 30 Billion by 2020. In the “Global Point-of-Care Diagnostics Market Outlook 2020” report, the global POCT industry has been shown at a very crucial stage with POCT expanding into diverse disease areas, such as cancer and HIV diagnostics. The coming years will witness POCT take over routine diagnostics as focus would shift from ‘curative’ onto ‘preventive care with enhanced patient involvement.’
Currently, the United States accounts for almost 45% of the total POCT market, followed by regions, such as Europe and Japan. In these developed regions, the proliferation of transportable, portable and handheld instruments along with ever-increasing incidence of lifestyle related disorders, such as diabetes has supported the growth of Point of Care testing. At the same time, rapid advancements in technology and infrastructure and the availability of diagnostic systems that cannot be employed in resource limited settings is expected to result in enhanced uptake of POCT in emerging nations. Countries such as Japan, China, India, Brazil and Mexico are expected to evolve as hot spots for development of the POCT technology in future.
The report provides a brief outlook of the IVD industry, covering major aspects, such as current market size, future growth, and current and future geographical segmentation. It also talks about the major players of IVD industry and their respective contribution to the current market.
The report then moves on to the global POCT industry, its current market size and future forecasts. Markets for major application segments such as glucose testing, blood chemistry etc. have also been discussed. Trends such as advanced micro fluidics, lab-on-a-chip assays as well as portable technologies have been elaborated. At the end, major players of the industry have been highlighted and a thorough profiling has been carried out to present the POCT product portfolios, business segmentations, strengths and weakness, and recent developments of every player.